DDX53 and neoplasm: Significantly, the treatment of amiloride at 10 μM for 6 h evidently inhibited exosome release from the CT26 and LLC tumor cells (Fig. 4d), indicating that the amiloride treatment profoundly decreased exosomes produced by the tumor cells.